← Back to Search

Hybrid Contact Lens

SynergEyes A2 Hybrid Contact Lens for Astigmatism

N/A
Waitlist Available
Led By Paul Kusy, OD, MS, FAAO
Research Sponsored by SynergEyes, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This is a multicenter study to evaluate the clinical performance of the SynergEyes A2 lens in patients with refractive errors with or without astigmatism.

Eligible Conditions
  • Astigmatism
  • Refractive Errors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Confirm current SynergEyes A2 lens design by evaluating clinical performance using objective and subjective parameters
Secondary outcome measures
Determine the best method for fitting the SynergEyes A2 hybrid contact lens

Trial Design

1Treatment groups
Experimental Treatment
Group I: SynergEyes A2 Hybrid Contact LensExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

SynergEyes, Inc.Lead Sponsor
2 Previous Clinical Trials
98 Total Patients Enrolled
Paul Kusy, OD, MS, FAAOPrincipal InvestigatorSynergEyes, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Apr 2025